Indian Pharmacopoeia Commission Represents India in Brazil

A delegation from the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India, led by Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, along with Dr. Pawan Saini and Dr. Shruti Rastogi, participated in the 16th International Meeting of World Pharmacopoeias (IMWP) and the accompanying Stakeholders’ Meeting held in Brasília, Brazil, from 15th to 17th June 2026.

The meeting, coordinated by the World Health Organization (WHO), brought together representatives from leading pharmacopoeias worldwide, including the Brazilian Pharmacopoeia (Brazil), European Pharmacopoeia (Europe), Indian Pharmacopoeia (India), Japanese Pharmacopoeia (Japan), Korean Pharmacopoeia (Republic of Korea), Mexican Pharmacopoeia (Mexico), Russian Pharmacopoeia (Russian Federation), British Pharmacopoeia (United Kingdom), United States Pharmacopeia (United States of America), State Pharmacopoeia of the Republic of Uzbekistan (Uzbekistan), Vietnamese Pharmacopoeia (Vietnam) and The International Pharmacopoeia of WHO.

During the meeting, Dr. Kalaiselvan presented key updates on the Indian Pharmacopoeia, highlighting recent advancements in pharmacopoeial standards, modernization initiatives, and India’s contributions towards global harmonization of medicine quality standards. Discussions during the meeting reaffirmed that the standards of the Indian Pharmacopoeia are comparable with leading international pharmacopoeias. India was also recognized for its leadership in developing and establishing quality standards for anti-tuberculosis medicines, anti-cancer therapeutics, blood and blood products, medicines used in the management of anaemia, and other complex pharmaceutical molecules, reflecting the country’s growing scientific, regulatory, and pharmacopoeial capabilities.(UPDATED ON 18TH JUNE 2026)